Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Steve Griffin is recorded as CFO, CEO and Board Member at Anika Therapeutics, Inc. (ANIK). Anika Therapeutics, Inc. reported in an 8-K filed January 8, 2026 that Steve Griffin was appointed Class III director, effective February 1, 2026. Anika Therapeutics, Inc. reported in an 8-K filed January 8, 2026 that Steve Griffin was appointed President and Chief Executive Officer, effective February 1, 2026. Anika Therapeutics, Inc. reported in an 8-K filed May 8, 2024 that Steve Griffin was appointed Executive Vice President, Chief Financial Officer and Treasurer, effective June 3, 2024. Steve Griffin has spoken on 5 earnings calls across 1 company, most recently for Anika Therapeutics, Inc. on July 29, 2026.
“On January 7, 2026, upon the recommendation of its Governance and Nominating Committee, the Board appointed Steve Griffin to join the Board, effective as of February 1, 2026.”
“Steve Griffin, currently serving as Executive Vice President, Chief Financial Officer and Chief Operating Officer, has been appointed by the Board to serve as the Company's President and Chief Executive Officer, effective as of February 1, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2026-02-01–present
2026-02-01–present
Recorded roles and call appearances connecting this person to public companies.
CFO, CEO, Board Member
2026-02-01–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
